No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
NAPA240517C7500
- 0.75
- +0.10+15.38%
15min DelayTrading May 13 09:36 ET
0.75High0.75Low
0.75Open0.65Pre Close11 Volume60 Open Interest7.50Strike Price825.00Turnover99.82%IV1.16%PremiumMay 17, 2024Expiry Date0.66Intrinsic Value100Multiplier4DDays to Expiry0.10Time Value100Contract SizeAmericanOptions Type0.7860Delta0.3252Gamma10.87Leverage Ratio-0.0309Theta0.0007Rho8.55Eff Leverage0.0026Vega
Intraday
- 5D
- 1D
News
Express News | Duckhorn Portfolio Inc : Jefferies Cuts Target Price to $11 From $13
Express News | NYSE Order Imbalance 104028.0 Shares on Buy Side
Duckhorn Portfolio Is Maintained at Outperform by Wedbush
Duckhorn Portfolio Is Maintained at Outperform by Wedbush
Wine Group The Duckhorn Portfolio Finds Positivity on Wall Street Amid Share Slide
Duckhorn Portfolio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 29.87% Wedbush $11 → $10 Maintains Outperform 03/11/2024 42.86% Citigroup $12.5 → $11 Maintains
The Duckhorn Portfolio, Inc.'s (NYSE:NAPA) Share Price Could Signal Some Risk
With a median price-to-earnings (or "P/E") ratio of close to 17x in the United States, you could be forgiven for feeling indifferent about The Duckhorn Portfolio, Inc.'s (NYSE:NAPA) P/E ratio of 17.2
Comments
Duckhorn's Q2 results were mixed with lower than expected revenue and declining sales volumes. Lowered full-year guidance and YoY revenue decline may concern investors, but robust gross margins and strong cost management are positive signs.
Duckhorn (NYSE:NAPA) Misses Q2 Sales Targets 1
Insider selling at Duckhorn Portfolio, including a recent sale by Pete Przybylinski at around the current price of US$9.61, is a negative sign. Despite the company's profitability and growth, this activity warrants careful consideration before investing.
Constellation Brands had a weak quarter with underwhelming earnings guidance. Duckhorn showed the slowest revenue growth and weakest full-year guidance. Boston Beer and Zevia PBC had mixed quarters with misses and beats on various estimates.
Despite insider buying, investment in the last three months is deemed insignificant. Ongoing analysis displays caution towards the company's transactions, mainly consisting of selling.
Bank of America analyst Peter Galbo downgraded the stock from 'Buy' to 'Neutral' and reduced the price target from $15 to $11. He suggests that the long-term benefits of the Sonoma-Cutrer Vineyards acquisition might outweigh the short-term dilution effect.
Read more